Recently, the Laboratory Department of the First Affiliated Hospital of Soochow University collaborated with Diffei Medical and published a prospective research article in the journal Infectious Diseases and Therapy (IF=6.119).By conducting both mNGS technology testing and conventional conventional tests (CTs) on 201 patients suspected of acute or chronic infection, the patients' clinical treatment plans were collected to explore the clinical application of mNGS technology in pathogen diagnosis and treatment decision-making. value.As a co-author, Diffei Medical participated in the data analysis and article writing of this study.

Introduction In July 2023, Professor Han Wei’s team from Qingdao Hospital of Rehabilitation University (Qingdao Municipal Hospital) published an article in the International Journal of Infectious Diseases (IF=8.4) that Copperophilus Girardi in convalescent patients with COVID-19 A case report of an infection caused by a medium, to explore the clinical value of mNGS technology in the rapid diagnosis of rare pathogen infection.

In August 2022, the team of Professor Tian Ye from the Urology Department of Beijing Friendship Hospital Affiliated to Capital Medical University, in cooperation with Difei Medical, published a case report in the journal Infection and Drug Resistance (IF=4.1772), describing a case of Corynebacterium striata. Diagnosis and treatment process of a 35-year-old male patient with congenital valvular endocarditis.Metagenomic sequencing of mitral valve and neoplastic tissue during treatment revealed Corynebacterium striata infection.

A few days ago, the Nanjing Science and Technology Bureau announced the 2023 Nanjing Engineering Technology Research Center Certification List.'Nanjing Infection Metagenome Engineering Technology Research Center' built by Difei Medical Technology (Nanjing) Co., Ltd. has been recognized through the procedures of district-level competent department recommendation, expert review, director's office meeting deliberation, and public announcement!

The development of modern science and technology promotes medical progress. Metagenomic next-generation sequencing (mNGS) technology has gradually entered the clinic from the laboratory and into the public eye, playing a key role in the diagnosis of many patients with difficult infections .

Difei Medical Technology (Nanjing) Co., Ltd. is a star enterprise under Nanjing Shihe Gene Biotechnology Co., Ltd.As a pioneer in the field of pathogenic microorganism detection in China, Difei Medical adheres to the corporate mission of 'born from the sense' and aims at 'innovating technology, transforming medical treatment' to create a more professional and clinically suitable testing product line , Escort the health of the public with advanced medical technology and services.